Dicerna Announces New Technology
We are very excited to learn of Dicerna's new technology to deliver medicines to cell types in the brain including oligodendrocytes.
Since PMD affects oligodendrocytes in the brain, we're eager to follow Dicerna's continued research in this area and hope it may facilitate new treatment options for PMD patients.